Similarly, another cross-sectional study also showed that RA patients who received 100 μg/d of MK-7 for 3 months showed a significant decrease in disease activity score, along with improved biomarker levels [erythrocyte sedimentation rate (ESR), CRP and MMP-3] [59]. Here, CRP is linked to rheumatoid arthritis.